037. Could somatostatin enhance the outcomes of chemotherapeutic treatment in small-cell carcinoma (SCLC)?

OBJECTIVE: Somatostatin is a peptide with a potent and broad antisecretory action, which makes it an invaluable drug target for the pharmacological management of pituitary adenomas and neuroendocrine tumors. Furthermore, somatostatin (SST) receptors (SSTR1, 2A and B, 3, 4 and 5) belong to the G prot...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Thorac Dis
Egile Nagusiak: Domvri, Kalliopi, Bougiouklis, Dimitrios, Zarogoulidis, Paul, Porpodis, Konstantinos, Xristoforidis, Manolis, Liaka, Alexandra, Eleutheriadou, Ellada, Organtzis, Ioannis, Kyriazis, George, Malecki, Bianka, Zarogoulidis, Konstantinos
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: AME Publishing Company 2015
Gaiak:
The Pan Hellenic Congress Abstracts
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4332059/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2015.AB037
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak